Business Context and Reporting Period
This Form 6-K filing by Nano Labs Ltd covers the month of April 2024, with the report dated April 15, 2024. The registrant is a foreign private issuer headquartered in Hangzhou, People's Republic of China. The filing serves to incorporate specific legal and transactional documents by reference into the Company's Registration Statement on Form F-3 (Registration No. 333-273968) and a prospectus supplement dated April 11, 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing focused on incorporating exhibits related to a securities offering rather than presenting periodic financial results.
Material Changes
No material changes to financial performance or operations are detailed in this text. The primary activity reported is the execution of a securities offering, evidenced by the inclusion of a Securities Purchase Agreement and a Placement Agent Agreement with Maxim Group LLC dated April 11, 2024.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors. It references legal opinions regarding the validity of Class A ordinary shares and tax matters in the Cayman Islands and PRC, which are incorporated as exhibits.
Investor Verification Checklist
- Verify the terms of the Securities Purchase Agreement (Exhibit 10.1) and the Pricing Release (Exhibit 99.2) to understand the capital raised.
- Review the Placement Agent Agreement (Exhibit 10.2) to confirm fees and obligations to Maxim Group LLC.
- Confirm the validity of the Class A ordinary shares as outlined in the legal opinion from Maples and Calder (Exhibit 5.1).
- Check the Registration Statement on Form F-3 for the full prospectus details referenced in this filing.